Peripheral artery disease trials in Hong Kong

3 trials · From ClinicalTrials.gov, checked 14 November 2026. Ask the study team whether a trial fits you.

• Phase 2/3Taking people
  Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)

  Where

  Ho Man Tin, Pok Fu Lam, Tsuen Wan

  Age

  18 years and over

  People

  3,110 worldwide

  Run by

  CSL Behring

  See details and how to joinNCT05485961 · EU 2022-500273-14-00
• No phaseTaking people
  SELUTION4BTK Trial

  Where

  Hong Kong

  Age

  18 years and over

  People

  376 worldwide

  Run by

  M.A. Med Alliance S.A.

  See details and how to joinNCT05055297
• No phaseTaking people
  Improving Walking Performance in Patients With Peripheral Artery Disease Through Wearable Activity Trackers

  Where

  Hong Kong

  People

  70

  Run by

  Chinese University of Hong Kong

  See details and how to joinNCT07012070